Inactive Instrument

Zalicus Inc Share Price Nasdaq

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2018	Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc.	CI
2018	Praxis Precision Medicines, Inc. completed the acquisition of Z944 assets from EPIRUS Biopharmaceuticals, Inc. (OTCPK:EPRS.Q).	CI

Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc.	09/18/09	CI
Praxis Precision Medicines, Inc. completed the acquisition of Z944 assets from EPIRUS Biopharmaceuticals, Inc. (OTCPK:EPRS.Q).	31/18/31	CI
Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc.	19/18/19	CI
Praxis Precision Medicines, Inc. agreed to acquire Z944 assets from EPIRUS Biopharmaceuticals, Inc. (OTCPK:EPRS.Q) for $1 million.	18/18/18	CI
Notice of Intent of Asset Sale Filed by EPIRUS Biopharmaceuticals, Inc.	11/17/11	CI
Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc.	19/16/19	CI
EPIRUS Biopharmaceuticals, Inc.(OTCPK:EPRS.Q) dropped from S&P TMI Index	05/16/05	CI
EPIRUS Biopharmaceuticals, Inc.(OTCPK:EPRS.Q) dropped from NASDAQ Composite Index	03/16/03	CI
EPIRUS Biopharmaceuticals, Inc. Announces Management Resignations	25/16/25	CI
EPIRUS Biopharmaceuticals, Inc. Filed for Bankruptcy	25/16/25	CI
EPIRUS Biopharmaceuticals, Inc. Announces Executive Termination	02/16/02	CI
Polpharma S.A. completed the acquisition of EPIRUS Biopharmaceuticals (Netherlands) B.V. from EPIRUS Biopharmaceuticals, Inc..	30/16/30	CI
Polpharma S.A. entered into a binding term sheet to acquire EPIRUS Biopharmaceuticals (Netherlands) B.V. from EPIRUS Biopharmaceuticals, Inc. for $3.5 million.	14/16/14	CI
EPIRUS Biopharmaceuticals, Inc. Announces Executive Changes	10/16/10	CI
EPIRUS Biopharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt	29/16/29	CI

EPIRUS Biopharmaceuticals, Inc. is in bankruptcy.

Sector

	1st Jan change	Capi.
IQVIA HOLDINGS INC.	+1.51%	42.75B
LONZA GROUP AG	+49.22%	41.61B
MODERNA, INC.	+8.57%	41.34B
CELLTRION, INC.	-12.36%	26.59B
ICON PUBLIC LIMITED COMPANY	+8.92%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-25.13%	18.12B
MEDPACE HOLDINGS, INC.	+29.17%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.12%	11.76B
UNITED THERAPEUTICS CORPORATION	+6.35%	11B